FOLFOXIRI‐Bevacizumab or...

The Oncologist 2021 / 01

FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS / BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis

Pietrantonio, Filippo, Fucà, Giovanni, Rossini, Daniele, Schmoll, Hans‐Joachim, Bendell, Johanna C., Morano, Federica, Antoniotti, Carlotta, Corallo, Salvatore, Borelli, Beatrice, Raimondi, Alessan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Oncologist
DOI:
10.1002/onco.13642
Date:
January, 2021
File:
PDF, 984 KB
2021
Conversion to is in progress
Conversion to is failed